Parlcsak and Bode: Gut pcrmeabiiity of K 400, M r 1500, M r 4000 and M r 10000 polyethylene glycol in man 813 Eur. J. Clin. Chcm. Clin. Biochem. Vol. 32, 1994, pp. 813-820 © 1994 Summary: Polyethylene glycol has been in use for a number of years for the assessment of gut permeability. The methods so far employed are usually limited to polyethylene glycols in the low relative molecular mass r nge (up to M T 1300). We developed a method for the simultaneous determination of gut permeability to M r 400, M r 1500, Af r 4000 and M r 10000 polyethylene glycol, by applying a single oral dose of an appropriate mixture of these polyethylene glycols. After extraction from 24 h-urine, M T 1500, A/ r 4000 and M T 10000 polyethylene glycol were quantified by size exclusion chromatography, while M r 400 polyethylene glycol was determined by reversed phase chromatography. The detection limit of polyethylene glycol in the relative molecular mass r nge between M r 1500 and Μ τ 10000 was found to be 0.2 mg/1 urine, and the detection limit of Af r 400 polyethylene glycol 5 mg/1 urine. Recovery of the polyethylene glycols (N = 6) were 86.6% (CV: 4.8%) for H 400, 94.1% (CV: 7.2%) for M r 1500, 97.1% (CV: 5.5%) for M r 4000 and 97.4% (CV: 5.6%) for M r 10000.
Introduction
. . i ", --« r nge between M r 400 and M r 600 (13) (14) (15) (16) (17) (18) (19) or around years, especially in patients with chromc inflammatory " bowel diseases. Until now, almost all the compounds · used to measure the intestinal permeability have been of Thus, intestinal permeability has been measured with low relative molecular mass (M T 180--M r 380). These either only low-Af r substances, or one containing radiohave been mannitol (1) and rhamnose (2) , frequently in nuclides. A non-invasive test permitting the simultacomtynation with a disaccharide such s cellobiose (3, neous determination of human gut permeability to com-4) or lactulose (5) (6) (7) . In many cases, radioactive sub-pounds in both the low and high relative molecular mass stances such s 51 Cr-EDTA (8) (9) (10) , "Tc-DTPA (11), r nge not containing radioactive components would be desirable. ' ) This study was supported by the Robert.Bosch-Stiftung (grant ™* ideal substance must be neither toxic nor metabo-F2).
Used by either man or the intestinal flora. Polyethylene glycol meets all these demands (18) , but its poor separability by reversed phase high performance liquid chromatography (RP-HPLC), and its unsatisfactory volatibility in gas chromatography have so far limited its use to the maximum relative molecular mass of M r 1300 (18, 20, 23, (24) (25) (26) . With the exception of polyethylene glycol M T 3000 and M T 4000, which were determined by open gel chromatography (27) (28) (29) or by a turbidimetric procedure (30) , no high M r polyethylene glycols have been used s markers in the systematic assessment of permeabiiity in man to our knowledge.
In this study, measurement of the simultaneous absorption of the four M r 400, M T 1500, M r 4000 and Μ τ 10 000 polyethylene glycols has been made possible by optimizing the percentage of each relative molecular mass r nge in one orally administered mixture. The method was tested for reproducibility and applicability. The permeabiiity measured in a group of patients with Crohn's disease (N = 10) was compared with that of a group of healthy Qpntrols (N = 21).
Materials and Methods

Reagents and Instrumentation
Chloroform p.a., methanol p.a. and Λ/ Γ 400, M T 4000, M v 10000 polyethylene glycols were purchased from Merck, Darmstadt, Germany. A/ r 1500 polyethylene glycol was obtained from Serva, Heidelberg, Germany. Teflon filters (0.45 μηι) were supplied by Aldrich, Steinheim, Germany.
All solvents were removed in a vacuum centrifuge (Bachhofer, Reutlingen, Germany). The Separation was carried out on a semipreparative column (500 mm X 8 mm), fllled with Lichrospher Diol 5 μηι 100 (Merck, Darmstadt). This column was protected by a pre-column (20 mm x 4 mm), fllled with the same material. M r 400 polyethylene glycol was separated on a column (250 mm X 4 mm) containing Nucleosil 7C8 (Macherey-Nagel, D ren, Germany). All polyethylene glycol fractions were quantified by measuring the differential refraction index (type ERMA 7512, ERC, Alteglofsheim, Germany). The Signals of this detector were evaluated by an Integrator (type 2000 D, Merck, Darmstadt, Germany).
Polyethylene glycol application and extraction
Each test subject ingested 2 g M r 400, l .5 g H 1500, 5 g M r 4000 and 10 g M r 10000 polyethylene glycol, all dissolved together in 100 ml of water; this solution was given s a drink after breakfast. Urine was collected during the next 24 hours. Hundred ml of the homogenised urine were stored at -20 °C and analysed within 6 months. For analysis, two 45 ml volumes of the urine were centrifuged for 10 minutes at 1000g. Clear supernatant (40.0 ml) was extracted with 3.0 ml Chloroform by vigorous shaking (2 min). The lowest, emulsified, chloroform/urine layer was transferred into centrifugation tubes. The urine was extracted once more with 2.0 ml Chloroform. After centrifugation, the two chlorof rm/urine emul· sions were combined. The supernatant urine was used for determination of M r 400 polyethylene glycol.
water. After rernoval of water, the remaining Chloroform layer was weighed. The loss of polyethylene glycol during the extraction procedure was determined by calculating the final volume of Chloroform against the Start volume. The M r 1500, M r 4000 and M r 10 000 polyethylene glycols remaining in the residue after evaporation of Chloroform were extracted with 400 μΐ of HPLC solvent (methanol/ water, 66 + 34, by vol.) for ten minutes in an ultrasonic bath (50 °C). The resulting Suspension, was filtered through a teflon membrane fllter (0.45 μηι) and 200 μΐ of this solution were applied to the HPLC at a flow rate of l ml/min (method A).
Reversed phase chromatography of M r 400 polyethylene glycol
Four ml of the urine, remaining after extraction with Chloroform, were evaporated. For complete dissolutiori of M r 400 polyethylene glycol, the residue was extracted with l ml of methanol in an ultrasonic bath at 50 °C for 30 min and centrifiiged (2500 g for 5 min). Fivehundred μΐ of the clear supernatant were evaporated to dryness and the residue redissolved in 400 μΐ mobile phase (methanol/water 20 + 80, by vol.). Hundred μΐ of this solution were quantified by reversed phase chromatography (Nucleosil 7C8, l ml/min, method B, modification of a method described in 1. c. (24)). To minimize difficulties during the determination of M f 400 polyethylene glycol ( fig. 6 ), peak area of the M r 418 compound (26.09 min) was used for calculation of M r 400 permeabiiity. This compound has shown the lowest inteiference with the initial background peak arid the lowest difference to the theoretical relative molecular mass ratio M T 400. Recovery was calculated s the quotient of the peak area of the urine-extracted compound and the peak area of the fraction in Standard solution, directly employed in HPLC.
Patients and healthy volunteers
To test the applicability of this procedure, the permeabiiity of the gut to all four polyethylene glycol molecular weight fractions was determined in a group of healthy controls (N = 21) and a group of patients with Crohn^s disease (N = 10). The diagnosis of Crohn's disease was con rrned by X-ray and/or endoscopy findings. The average Crohn's disease activity index (CDAI s reported by Beck (31)) of the patients with GO/W'S disease was 140 ±21. None of the patients had undergone resection; their average age was 39.7 ± 4.4 years and their average body weight 70.2 ± 7.7 kg (mean ± SEM).
The members of the control group did not differ from those of the patient group in either age (37.0 ± 2.9 a) or weight (72.0 ± 4.34 kg), nor was there any difference in sex distribution. Creatinine clearance was normal in all subjects.
Mass ratio of ingested M T 400, M T 1500, M r 4000 and Λ/ Γ 10000 polyethylene glycols
The mass ratios of the different polyethylene glycols in the mixture employed were optimized in such a way s to obtain cornparable concentrations of M t 1500, M r 4000 and M r 10000 polyefhylene glycol in the urine samples. In this way it was possible to quantify these three fractions in a single Chromatographie analysis. The arnount of M T 10000 polyethylene glycol employed was limited to 10.0 g because of the laxative effect of this compound. The ingested amount of M r 400 polyethylene glycol was four times. s large s M r 1500 polyethylene glycol beeause a less sensitive method of analysis was used.
Size exclusion chromatography of M T 1500, Μ τ 4000 and M r 10000 polyethylene glycol
The chloroform/urine emulsion was centrifuged (2500 g, 20 min at 4 °C) and the clear Chloroform layer washed twice with distilled Calibration, linearity, reproducibility, recovery, stability and detection limits Before polyethylene glycol ingestion, urines of both groups were checked for the appearanee of disWbing peaks in the chromato- 
Results
Chromatographie Separation and extraction of different polyethylene glycoi fractions
Organic biopolymers, usual matrices for Separation of constituents according to their relative molecular mass, showed after a few Chromatographie runs with samples gained by the described procedure a fast increase in pressure over the maximum limit. Because of its porosity (about 100 ) and its pressure stability, semipolar reversed phase material (Diol) proved highly suitable for size exclusion chromatography, when all attraction phenomena of polyethylene glycoi to the stationary phase were suppressed. In an attempt to find the best mobile phase, the methanol/water solvent was optimized. the approximated function ( fig. 1 ). Optimal conditions were found to differ for each M T fraction, ranging from 54 + 46 (methanol/water) for M r 400 polyethylene glycoi to 68 + 32 for A/ r 10000 polyethylene glycoi. Satisfactory simultaneous Separation of all four fractions was obtained at a mixture of 66 + 34. Under these conditions, there was no increase in pressure over more than 100 runs with samples gained by the described procedure.
Under the given conditions of Chloroform extraction, migration of Μ τ 400 polyethylene glycoi from the urine into the organic layer was below the detection limit. This lack of extractability of Μ τ 400 polyethylene glycoi made a separate analysis necessary. M r 1500, Μ τ 4000 and M,. 10000 polyethylene glycoi, on the other hand, were emiched completely in the Chloroform layer by twofold extraction of the organic solvent. A third Chloroform extraction contained no detectable traces of any of this three polyethylene glycoi fractions.
No disturbing Signals at relevant retention times for M r 1500, A/r 4000 and M r 10000 polyethylene glycoi were obtained after extraction (method A) of urines containing no polyethylene glycoi ( fig. 2) . Figure 3 shows the chromatogram of an evaporated Chloroform extract of a urine stocked with 500 mg/1 of each of the four polyethylene glycoi fractions. A chromatogram of a Standard solution of M T 400 polyethylene glycoi (2 g/l) is shown in figure 4 . Urine without polyethylene glycoi showed no disturbing peaks at the retention time of Af r 418 ( fig.  5 ). After oral administration of the described polyethylene glycoi mixture, the content of Af r 400 polyethylene glycoi in the excreted urine could be quantified ( fig. 6 ). Permeability of A/ r 400 polyethylene glycoi was calculated s the permeability of M r 418 polyethylene glycoi (26.09 min in fig. 6 ). The detection limit of method A, defmed by a signal-tonoise-ratio of 5 : l, was determined for M T 1500, Μ τ 4000 and M T 10000 polyethylene glycol to be 0.2 mg/1 each. The detection limit for method B (A/ r 400 polyethylene glycol) was 5 mg/1, which reflected the lower enrichment of polyethylene glycol by this method. The recovery of polyethylene glycols (N = 6) in frozen urine measured on different days was 86.6% (CV: 4.8%) for M r 400, 94.1% (CV: 7.2%) for M T 1500, 97.1% (CV: 5.5%) for M r 4000 and 97.4% (CV: 5.6%) for M r 10 000. The amount of polyethylene glycol proved to remain stable over a storage time of up to six months.
Permeability in patients with Crohn's disease and in healthy controls
The excretion of M T 400 polyethylene glycol by patients with Crohn's disease (34.4 ± 5.5%, mean ± SEM) did not differ from that in the control group (33.6 ± 3.2%).
There was also no difference of the relative amount of M r 1500 polyethylene glycol in the permeated urine in patients with Crohn's disease (5.22 ± 2.27%) s compared with that of the healthy controls (1.09 ± 0.26%, 0.05 < p < 0.10). The excretion of M T 4000 polyethylene glycol was significantly higher in patients with C/O/W'S disease (0.462 ± 0.177%) than in the control group (0.049 ± 0.012%, p < 0.05). M r 10000 polyethylene glycol was detectable in the urine in only one of the 21 healthy controls (detection limit at 0.2 mg/1), but in nine of the patients with Crohn's disease (0.229 ± 0.070%o, p < 0.001).
With the employed amounts of polyethylene glycols, laxative effects were neither observed in the group of patients with Crohn's disease nor in that of healthy volunteers. This fact corresponds well with results published by other authors (18, 19, 21, 23) .
Discussion
Polyethylene glycol was first used s a marker for rneasuring the permeability of the gut by Chadwick (18) . Several other authors recognized the importance of the relative molecular mass of this permeability marker, but due to analytical eonstraints employed a maximal relat ive molecular mass of only M r 1300 (20, (23) (24) (25) (26) . Polyethylene glycol, having a relative molecular mass of up to M T 4000, was employed in only two studies, and analysed with the time-consuming open gel chromat graphy (27, 28) . The new method described readily allows the simultaneous deterrnination of gut permeability to polyethylene glycols ranging from M r 400 to Μ τ 10000 ingested simultaneously. Due to the urine sampling tirne (24 h), this procedure may serve to assess the overall permeability of compounds over a wide relative molecular mass r nge from the whole intestine into the systemic blood stream.
Poor pressure stability of the gel· colurnns and the possibility of microbiological degradation rn ke it difflcult to work with those organic polymers often used s a Separation matrix for size exclusjibn chromatography. Silica, which does not have these disadvantages, is porous not only in its natural, but also in a modified state. This porosity makes it suitable for size exclusion chromatography. To obtain a r nge for optimization of the solvent, a semipolar Diol-phase was used s stationary phase. In order to be able to utilize the size exclusion effects, the strength of the mobile phase was adjusted so s to suppress all surface (adsoφtion and reverse phase) effects.
Mixtures of acetone, cetonitrile, tetrahydrofuran and methanol with water were all suitable for Separation of the polyethylene glycol fractions, but the mobile phase used was optimized with methanol äs the organic component (flg. 1), resulting in high detection limits, reflecting the low refraction index of methanol.
Because of confounding elements in the urine, a method for the determination of M T 400 polyethylene glycol by reversed phase-HPLC developed earlier (24), had to be modified.
Some authors have used M T 400 polyethylene glycol for determination of gut permeability under comparable conditions (16, 19, 24, 32) . Their results correspond well, in terms of order of magnitude, with the values determined in this study, although the amount of M T 400 polyethylene glycol ingested was considerably higher (up to 5 times) than in the present study. Thus, the uptake and excretion of M r 400 polyethylene glycol does not seem to correlate with the amount ingested.
The use of polyethylene glycol fractions with a mölecu-lar weight of between M r 400 and M r 1300 äs permeability markers resulted in the detection of 20-50% of the ingested polyethylene glycol in the urine, even in persons with no signs of any bowel disease (14-16, 19, 21, 33) . Among others, the high excretion rate of ingested polyethylene glycol may be the reason for the contradictory results obtained when comparing permeability in patients with Crohn's disease and in healthy controls -the permeability to polyethylene glycol of less than M r 1300 in the patients was found to be comparable (16, 19) , higher (14, 33) or lower (15, 21) than in controis.
The importance of employing polyethylene glycols with M T > 1500 is underscored by comparing the renal excretions of M r 4000 and M T 10000 polyethylene glycol in patients with Crohn's disease and in healthy controls. The excretion of 4000 polyethylene glycol in the patients was found to be ten times äs high äs in the controls.
10000 polyethylene glycol was detected in the urine of only one out of 21 persons in the control group, but in that of nine out of ten in the Crohn's disease group.
When using polyethylene glycol to investigate changes in intestinal permeability relating to certain bowel diseases, it may be important to be aware of the significance of the M T of polyethylene glycol used. A decisive factor for the permeation of any compound through the epithelium of the mucosal barrier in the gut is the spatial extent of the molecule. The average diameter of this molecule is directly related to the cübe root of relative molecular mass. In any case, the correlation between the diameter and the cube root of the relative molecular rnass does not depend on the exact shape of the molecule. Doubling the average diameter of a mole·ĉ ule requires an eight-fold increase in molecular mass.
A search for the mathematical function best able to express the correlation between the diameter of the molecule and excretion showed the best ernpiric approximation to be the exponentional one:
relative excretion ~ b (*P lecuIar diameter) and, thus,
where b is the basis of the exponential function and M r the relative molecular mass of the permeating molecule. This proportionality can also be expressed äs an equation by introducing the proportionality factor k: Further investigations will be needed to show whether the parameters of the äböve regressed equation (especiälly b) can serve äs factors for the assessment of inflammatory bowel diseases. Figure 7 shows that, äs compared with healthy controls, the percentage permeability in patients with Crohn's disease was changed only slightly in the low, but markedly in the high molecular ränge. This may suggest an ältered selectivity of leaky places in the mucosal gut barrier räther than a chänge in their number.
The determination of permeability of high M r compounds in other intestinal disjEjases might also be impor-tant because of their potentially antigenic efFects. When investigating the relative molecular mass distribution of endotoxins in human feces, for example, we were able to identify endotoxins ranging between A/ r 1500 and M r 25 000 (34). The fact that this ränge overlaps with that of the polyethylene glycol used in the present study (A/r 400-M r 10000) underscores the importance of measuring permeability in the high-M r ränge.
